Multiple-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects

ConclusionConcomitant administration of ozanimod with PSE, a sympathomimetic agent, did not potentiate the effects on blood pressure.Trial RegistrationNCT03644576.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research